Literature DB >> 24179612

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Rosa Zampino1, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto, Luca Rinaldi, Ciro Romano, Luigi E Adinolfi.   

Abstract

The liver has a central role in regulating inflammation by its capacity to secrete a number of proteins that control both local and systemic inflammatory responses. Chronic inflammation or an exaggerated inflammatory response can produce detrimental effects on target organs. Chronic hepatitis C virus (HCV) infection causes liver inflammation by complex and not yet well-understood molecular pathways, including direct viral effects and indirect mechanisms involving cytokine pathways, oxidative stress and steatosis induction. An increasing body of evidence recognizes the inflammatory response in chronic hepatitis C as pathogenically linked to the development of both liver-limited injury (fibrosis, cirrhosis and hepatocellular carcinoma) and extrahepatic HCV-related diseases (lymphoproliferative disease, atherosclerosis, cardiovascular and brain disease). Defining the complex mechanisms of HCV-induced inflammation could be crucial to determine the global impact of infection, to estimate progression of the disease, and to explore novel therapeutic approaches to avert HCV-related diseases. This review focuses on HCV-related clinical conditions as a result of chronic liver and systemic inflammatory states.

Entities:  

Keywords:  Cytokines; Extra-hepatic diseases; Hepatic disease; Hepatitis C virus; Inflammation; Oxidative stress

Year:  2013        PMID: 24179612      PMCID: PMC3812455          DOI: 10.4254/wjh.v5.i10.528

Source DB:  PubMed          Journal:  World J Hepatol


  142 in total

Review 1.  Structure and function of gC1q-R: a multiligand binding cellular protein.

Authors:  B Ghebrehiwet; E I Peerschke
Journal:  Immunobiology       Date:  1998-08       Impact factor: 3.144

2.  Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.

Authors:  Y S Huang; S J Hwang; C Y Chan; J C Wu; Y Chao; F Y Chang; S D Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1999-06

Review 3.  Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress.

Authors:  Helmut K Seitz; Felix Stickel
Journal:  Biol Chem       Date:  2006-04       Impact factor: 3.915

4.  High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma.

Authors:  G Dalagiorgou; N Vassilaki; P Foka; A Boumlic; A Kakkanas; E Kochlios; S Khalili; E Aslanoglou; S Veletza; G Orfanoudakis; D Vassilopoulos; S J Hadziyannis; J Koskinas; P Mavromara
Journal:  J Gen Virol       Date:  2011-02-09       Impact factor: 3.891

5.  Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.

Authors:  Dylan Burdette; Adam Haskett; Lance Presser; Steven McRae; Jawed Iqbal; Gulam Waris
Journal:  J Gen Virol       Date:  2011-10-12       Impact factor: 3.891

Review 6.  Pathophysiology of insulin resistance.

Authors:  Giorgio Sesti
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-12       Impact factor: 4.690

7.  Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1.

Authors:  Sampa Pal; Stephen J Polyak; Nazneen Bano; Wan Chong Qiu; Robert L Carithers; Margaret Shuhart; David R Gretch; Aditi Das
Journal:  J Gastroenterol Hepatol       Date:  2010-01-14       Impact factor: 4.029

Review 8.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

9.  Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.

Authors:  Hayato Nakagawa; Shin Maeda; Haruhiko Yoshida; Ryosuke Tateishi; Ryota Masuzaki; Takamasa Ohki; Yoku Hayakawa; Hiroto Kinoshita; Minoru Yamakado; Naoya Kato; Shuichiro Shiina; Masao Omata
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

10.  Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation.

Authors:  Kuan-Jen Chen; Chin-Kai Tseng; Fang-Rong Chang; Jin-Iong Yang; Chi-Chen Yeh; Wei-Chun Chen; Shou-Fang Wu; Hsueh-Wei Chang; Jin-Ching Lee
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  77 in total

1.  [Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1].

Authors:  Xiao-Jin Sun; Lin-Yan Ma; Meng-Xiao Zhang; Ying Wang; Pei Zhang; Chen-Chen Jiang; Hao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

3.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 4.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

Review 5.  Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Authors:  Luigi Elio Adinolfi; Riccardo Nevola; Giacomo Lus; Luciano Restivo; Barbara Guerrera; Ciro Romano; Rosa Zampino; Luca Rinaldi; Ausilia Sellitto; Mauro Giordano; Aldo Marrone
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

6.  Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.

Authors:  Albert Do; Denise A Esserman; Supriya Krishnan; Joseph K Lim; Tamar H Taddei; Ronald G Hauser; Janet P Tate; Vincent Lo Re; Amy C Justice
Journal:  J Gen Intern Med       Date:  2020-04-27       Impact factor: 5.128

7.  Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.

Authors:  Jyoti Barokar; Allen McCutchan; Reena Deutsch; Bin Tang; Mariana Cherner; Ajay R Bharti
Journal:  J Neurovirol       Date:  2019-07-07       Impact factor: 2.643

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

Review 9.  Assessing cardiovascular risk in hepatitis C: An unmet need.

Authors:  Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Hepatol       Date:  2015-09-08

Review 10.  Hepatitis C virus and neurological damage.

Authors:  Shilu Mathew; Muhammed Faheem; Sara M Ibrahim; Waqas Iqbal; Bisma Rauff; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.